OTC across-the-board sodium warning use makes "sense," FDA tells NDMA.
This article was originally published in The Tan Sheet
Executive Summary
OTC ACROSS-THE-BOARD SODIUM WARNING IMPLEMENTATION MAKES "SENSE," FDA told the Nonprescription Drug Manufacturers Association in a Jan. 14 letter responding to NDMA's Sept. 20 comments on sodium labeling for OTC drugs ("The Tan Sheet" Oct. 7, 1996, p. 22). The agency published a final rule setting sodium content labeling requirements for OTCs intended for oral ingestion in the April 22 Federal Register ("The Tan Sheet" April 29, 1996, p. 8).